about
Correlation of human epidermal growth factor receptor protein expression and colorectal cancerHER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologistsIs overexpression of HER-2 a predictor of prognosis in colorectal cancer?Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system.The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing.Comparison of HER2 expression between primary colorectal cancer and their corresponding metastases.Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.HER2/neu testing in primary colorectal carcinoma.Significance of human epidermal growth factor receptor 2 expression in colorectal cancer.The clinical significance of HER2 protein amplification/expression in urinary bladder lesion.Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.Genomic markers of panitumumab resistance including ERBB2/ HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC).HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives.Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.Her-2/neu testing and therapy in gastroesophageal adenocarcinoma.Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer.RAS signaling pathways, mutations and their role in colorectal cancerRecent advances and future trends in the targeted therapy of metastatic gastric cancer.HER2 assessment by silver in situ hybridization: where are we now?HER2 expression status in diverse cancers: review of results from 37,992 patients.Pertuzumab in gastrointestinal cancer.Cardiotoxicity associated with targeted cancer therapies.Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory.Early response to ErbB2 over-expression in polarized Caco-2 cells involves partial segregation from ErbB3 by relocalization to the apical surface and initiation of survival signaling.KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer.(18)F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value.HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.Are biopsy specimens predictive of HER2 status in gastric cancer patients?Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?HER2 protein expression and HER2 gene amplification are infrequent in small intestinal carcinomas.Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma.Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer.Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
P2860
Q26801167-6878E86D-9934-41E8-ABCB-306F76EF1B52Q28078111-B508E81E-BD3C-4079-BB30-2831C510740CQ30856729-76176818-6E7A-4591-A780-CE3B9C8F0278Q31059013-E952558A-CA8C-4657-ADAD-D928D79442A1Q33618553-3E1BABF7-9F2A-4F80-A109-2865AF282FF1Q33626875-D136AE3D-2697-4E7F-921B-B9DA9A65D998Q33764191-AA13B718-91B6-41BA-9F73-CF60272F569BQ33913610-8D2E400A-A7E2-4A1C-9888-79088693F528Q33943812-DC24560F-E784-4EF2-8FF8-61F9179B08E2Q34499615-00A6E582-4B19-48D9-87B1-2912AAFC3FFAQ34585338-E8006DD5-7EB2-421C-AA2A-8FFF0FCEFE7EQ36034067-3D2121AF-D561-4600-9F0D-B1D45218E31EQ36548702-EA4096F0-5D4B-4B33-9EB1-1FF6E2328AB8Q37109905-2F23DE7A-0FA2-4A12-8F1C-541CB5F7E3E0Q37708897-A196C938-020F-4DD7-ACAC-C15692D7B92EQ37725990-62CA77BC-07DD-40CB-83D1-0F2704732803Q37824265-FD7DCED0-5DBF-435B-9AFB-5429DB08E81AQ38087507-BEE8AD2A-914E-44D5-A5BA-985B117B2A6DQ38116869-2044A5FA-E257-4ACE-9D55-D70F6E4D47EDQ38199128-98DFEFF9-AF30-4B4D-AEFF-B771935AF5AFQ38314355-33B0317C-0F85-46BB-9D4C-68F25FE4FC20Q38364900-2B4EB4BD-1C1B-474A-90C7-C355D5A9F642Q38653309-E99A280D-E9A3-4D3A-9182-4C9A8142EB79Q38819670-1C39F9BA-7462-4E21-BA8D-5D0B1DB29742Q38827897-065AC238-D11E-4351-8DFA-55FF239903E4Q39686854-82A3DF7C-D471-4EB8-BCC7-4BC8750BCA7DQ39861972-17742C98-C25B-47B7-92CA-B75E451C815AQ41835781-D7830684-0DB0-4C3B-A125-A949B5CB7088Q43825401-258D894C-DD1B-414C-8BA3-A5F769A920D5Q44885327-F31385C4-872D-40A1-80D5-C74E36C35AC7Q47164059-4E367714-12E4-4548-9148-7FAED83EDC4FQ50964844-D1FA658C-733B-45BB-874F-26BB9BF5608AQ53091400-6CA753CD-4435-40A3-88A7-A84BB8D0A631Q53128686-9593B68F-80E8-4C1E-A585-30EAC890C8B8Q53134672-EA545639-80CD-468F-8FAA-AD3C2EF80FCCQ54501568-36FCA6DC-CDFE-43F4-8562-5E656801E44EQ54962247-4C20756F-F91E-4490-857E-43D84FF030E7
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
HER 2/neu protein expression in colorectal cancer
@ast
HER 2/neu protein expression in colorectal cancer
@en
type
label
HER 2/neu protein expression in colorectal cancer
@ast
HER 2/neu protein expression in colorectal cancer
@en
prefLabel
HER 2/neu protein expression in colorectal cancer
@ast
HER 2/neu protein expression in colorectal cancer
@en
P2093
P2860
P356
P1433
P1476
HER 2/neu protein expression in colorectal cancer
@en
P2093
Ch Zielinski
W Scheithauer
P2860
P2888
P356
10.1186/1471-2407-6-123
P407
P577
2006-05-08T00:00:00Z
P5875
P6179
1032228410